Stone Ridge Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Stone Ridge Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-54,837	Closed	-$219K	–	970
2019 Q4	$219K	Hold	54,837	–	–	0.01%	866
2019 Q3	$269K	Buy	54,837 +3,900	+8%	+$21.8K	0.02%	906
2019 Q2	$310K	Buy	50,937 +40,710	+398%	+$216K	0.02%	902
2019 Q1	$59K	Buy	+10,227	New	+$106K	﹤0.01%	1100
2018 Q4	–	Sell	-56,590	Closed	-$1.1M	–	1381
2018 Q3	$1.1M	Hold	56,590	–	–	0.06%	422
2018 Q2	$1.45M	Hold	56,590	–	–	0.08%	274
2018 Q1	$1.14M	Hold	56,590	–	–	0.07%	335
2017 Q4	$1.14M	Buy	+56,590	New	+$1.11M	0.07%	326

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Stone Ridge Asset Management's DPLO Position: Q1 2020 in Review

Stone Ridge Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 54,837 shares — an estimated $219K sold.

Stone Ridge Asset Management first reported a position in DPLO in Q4 2017 and held it in 8 quarters. The position peaked at $1.45M in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Stone Ridge Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Stone Ridge Asset Management sold 54,837 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $219K.
Stone Ridge Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2017 and held it in 8 quarters.
Stone Ridge Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $1.45M in Q2 2018.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Stone Ridge Asset Management's 13F filing for Q1 2020, filed 5 May 2020.